Eisai Creates Center for Genetics Guided Dementia Discovery

Published 3/29/2019

Eisai - Center for Genetics Guided Dementia Discovery

^{Courtesy of TRIA.}

Eisai - Center for Genetics Guided Dementia Discovery

^{Courtesy of The Davis Companies.}

Cambridge, Mass.

Eisai is building the $100 million Center for Genetics Guided Dementia Discovery (G2D2) in Cambridge, Mass. Sited in the newly constructed Alewife Research Center, the 50,000-sf neuroscience facility will support exploratory drug research on next-generation dementia therapeutics. Featuring numerous interaction zones and huddle areas, the center will provide open offices, a collaboration hub, flexible meeting rooms, and multidisciplinary open labs for the study of biology, chemistry, and automation. The project team includes architect TRIA, general contractor John Moriarty & Associates, and MEP/FP engineer AHA Consulting Engineers. Occupancy is expected in mid-2019.